Background: Acute lung injury (ALI) is characterized by rapid induction of inflammation at the alveolar-capillary membrane, and immunosuppressive mechanisms were shown to contribute to its resolution. Despite the central role of lymphocytes in initiating and mediating an inflammatory response, their influx dynamics in ALI has not been examined. Methods: We collected mini-BAL samples from the lung of ALI patients over a maximum period of 7 days, and examined the lymphocyte composition. Results: CD3 + CD4 + IFN-gamma + Th1 cells were detected early on in all patients examined, while IL-10-producing B cells and CD3 + CD4 + CD25 hi Foxp3 + Treg cells appeared later. Interestingly, IL-10-producing B cells appeared earlier than Tregs in most subjects, which possibly exerted anti-inflammatory function before Tregs. We then found that in patients with earlier recruitment of IL-10-producing B cells, the magnitude of Th1 inflammation decreased significantly over time, which was not observed in patients with later recruitment of IL-10-producing B cells. Furthermore, early IL-10-producing B cell recruiters also had significantly earlier recruitment of Tregs and better survival than late IL-10-producing B cell recruiters. Conclusion: This study provided data on the alveolar infiltration of lymphocytes during ALI, which suggested an inhibitory role of IL-10-producing B cells in ALI and emphasized the importance of controlling inflammation during the initial stage of ALI.
Introduction
Acute lung injury (ALI) is a major cause of alveolar-capillary injury with high morbidity and mortality in critically ill patients [1, 2] . Despite extensive investigations aimed at ALI treatment, current management is mainly supportive, as the underlying mechanisms of ALI pathogenesis have not been fully identified and understood.
The early phase of ALI is characterized by acute inflammation of the alveolar-capillary membrane, resulting in an accumulation of neutrophils, macrophages and proinflammatory cytokines, which are thought to exacerbate inflammation and lung damage [3] . Resolution of inflammation is thought to be driven by immunosuppressive mechanisms, including elevated expression of antiinflammatory cytokines [4] , clearance of neutrophils [5] , and increase of regulatory T (Treg) cell-mediated immunosuppression [6] [7] [8] . Previous studies have shown that Treg transfer into intratracheal LPS-challenged Rag-1-/-mice resulted in earlier resolution of inflammation and reduced levels of alveolar proinflammatory cytokines [6] ; adoptive transfer of Treg cells also resolved CXCL12-CXCR4-induced fibroproliferation, a condition associated with worse outcomes [9, 10] . These studies highlight the participation of immunoregulatory mechanisms in lung injury resolution.
Studies on the regulatory functions of B cells in ALI have been scarce. But in other diseases, B cells have been shown to inhibit Th1/Th17 inflammation during acute inflammation [11] , suppress induction of autoimmune disorders [12] [13] [14] , contribute to the resolution of chronic colitis [15] , and suppress antigen-specific T cell inflammations in infection [16, 17] . Multiple B cell subsets in mice and humans have been ascribed with regulatory functions, including B-1 cells, marginal zone B cells, and plasmablasts [18, 19] . In all of these populations, IL-10 production has been considered the primary mediator of immune suppression [20] . Previously, we found that the frequencies of CD19
hi regulatory B cells (Breg) were elevated in senior pneumonia patients and were correlated with reduced risk for ALI development, suggesting a potential role of Breg in inhibiting ALI development. The precise mechanism of Breg action in the initiation and resolution of ALI is still unclear.
In this study, we examined the alveoli of ALI patients over the course of ALI onset, development, and resolution. Our data suggest that early recruitment of IL-10-producing Breg into the alveoli was correlated with early Treg recruitment and contributed to improved ALI outcome.
Materials and Methods

Study population
Twenty-eight ALI patients, diagnosed according to the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference, and the American-European Consensus Conference statements, were recruited. All patients had been previously diagnosed with bacterial pneumonia prior to ALI [21] . Exclusion criteria included diffuse alveolar hemorrhage, severe chronic respiratory disease, directive to withhold intubation, severe chronic liver disease (defined as a Child-Pugh score of >10), malignancy, using of chronic high-dose immunosuppressive therapy (steroids with equivalent prednisone >0.5 mg/kg per day or cytotoxic agents for immunologic disorders), immunosuppression, ALI induction of other causes such as viral infection and sepsis, and chronic heavy smokers and alcohol abusers. Demographic and clinical information of the study population is shown in Table 1 . Written informed consent was obtained from each study subject. All procedures followed the guidelines of the Declaration of Helsinki and were approved by the Ethics Boards of East Hospital and Affiliated Bayi Brain Hospital. 
Flow cytometry
Cells were first incubated with Human TruStain FcX Fc Receptor Blocking Solution (BioLegend) for 10 min, and then with anti-human CD3, CD4, CD19 and CD25 monoclonal antibodies in staining buffer (PBS supplemented with 2% FBS and 0.1% sodium azide) for 30 min at 4 ˚C. In a subset of experiments, anti-human CD10, CD20, CD21, CD24, CD27 and CD38 were also included to analyze Table 1 . Demographic and baseline clinical characteristics of the study population. All continuous values were expressed as mean ± SD the surface marker expression of IL-10-producing B cells. Cells were then washed in staining buffer twice and permeabilized in Cytofix/Cytoperm Fixation/Permeabilization Solution (BD) for 15 min at 4 ˚C. Antihuman IFN-gamma (BioLegend), IL-10 and Foxp3 monoclonal antibodies (BD) were then added to the cells in diluted PermWash buffer (BD) for 30 min at 4˚C, after which the cells were washed and stained samples were run in a FACSFortessa cytometer (BD).
Statistics
All statistical analyses were performed using Prism 6 Software (GraphPad). Mean ± standard deviation was shown when applicable. P values less than 0.05 was accepted as statistically significant.
Results
IL-10-producing B cells are present in ALI patients
We first examined immune cell composition in ALI patients. Patients were enrolled within 4 days after ALI onset. Mini-BAL and blood samples were collected after enrolment at various time points between Day 0 (time of ALI onset) and Day 6. The immune cell composition in mini-BAL was analyzed by flow cytometry. We were able to find both CD3 +
CD19
-T cells and CD3 -CD19 + B cells in mini-BAL (Fig. 1A ). T cells and B cells are composed of various subsets with different functions. By using IFN-gamma as a Th1 functional marker, CD25 and Foxp3 as Treg markers, and IL-10 as a regulatory B cell functional marker, we observed that Th1, Treg, and IL-10-producing B cell subsets were present in mini-BAL (Fig. 1B) . The roles of Th1 and Treg infiltration in ALI have been studied previously. Here, we focused on IL-10-producing B cells [6, 23] . By surface marker expression, the majority of these B cells presented a CD10
-, CD20 lo/+ , CD27 + expression pattern, which is consistent with activated memory or differentiating plasmablast phenotypes (Fig. 1C ) [24, 25] . We did not find that these B cells were particularly high in terms of CD24 or CD38 expression, common markers of regulatory B cells in autoimmune diseases [26] .
Varying dynamics of IL-10-producing B cells were observed.
We then examined the dynamics of T cell and B cell subsets within the mini-BAL during ALI. Since not all patients were immediately enrolled after ALI onset, patient timelines were normalized according to the date of the onset instead of the date of the enrolment. We found that at Day 0, a strong influx of Th1 cells was present in all patients with Day 0 data available ( Fig. 2A) . In 10 out of 27 patients, the high frequency of Th1 cells persisted or further increased over the course of ALI, while in 17 out of 27 patients, the frequency of Th1 cells showed a decreasing trend, and had a lower Th1 frequency in the last mini-BAL sample (Day 4, 5 or 6, depending on the patient) compared to the first mini-BAL sample (Day 0, 1, 2, or 3, depending on the patient). The starting date of Treg influx, however, was highly variable, from as early as Day 0 to as late as (Fig. 2C) .
The influx of IL-10-producing B cells were inversely correlated with Th1 inflammation
IL-10-producing B cells were shown to suppress Th1 and cytotoxic T cell inflammation [16, 17] . Using the median of Day 1 after ALI onset as a divider, we grouped our patients into early IL-10-producing B cell recruiters, if IL-10-producing B cells first appeared at Day 0 and Fig. 2A ). These two groups of patients did not have a significant difference in terms of the initial (first mini-BAL) and final (last mini-BAL) magnitude of Th1 inflammation (Fig. 3A) . However, the early recruiters showed significant downregulation of Th1 frequency over the study period, as evident by the lower Th1 percentage in the last mini-BAL compared to the first, while no such downregulation was found in late recruiters (Fig. 3B) . producing B cell recruiters had significantly earlier Treg appearance in the mini-BAL than late recruiters (Fig. 4C) . Together, these data suggest that IL-10-producing B cells might influence the strength of Treg infiltration in the mini-BAL by increasing the Treg frequency and by facilitating Treg recruitment.
ALI patients with early IL-10-producing B cell infiltration showed improved prognosis
The effect of Treg cells in injury repair following ALI has been studied elsewhere [6, 7] . To evaluate the role of Th1 and IL-10-producing B cell influx in injury recovery after ALI onset, we followed the study patients for the disease outcome. While the initial Th1 influx did not affect the mortality after ALI, patients who survived the disease showed significantly lower final Th1 influx (Fig. 5A) , suggesting that the suppression of Th1 inflammation was crucial to the resolution of the disease. In addition, the early IL-10-producing B cell recruiters had significantly lower mortality than late recruiters (Fig. 5B) , implicating a role of IL-10-producing B cell influx in ALI resolution.
Discussion
Despite extensive studies on the exacerbating role of inflammation in ALI induction [3, 27, 28] , to the extent of our knowledge, the lymphocyte trafficking dynamics in ALI patients has not been examined in detail. Therefore, we collected ALI mini-BAL samples and analyzed the lymphocyte composition over a 7-day timeline. We first identified the presence of CD3 
Foxp3
+ Treg cells were present in only a subset of the ALI patients at the initial sample date, and gradually appear over the 7-day period. Similarly, IL-10-producing B cells also had varying influx dynamics in different patients, but interestingly, IL-10-producing B cells appeared earlier than Tregs in most subjects. We then examined the association between the dynamics of these cell types, and found that in patients with earlier recruitment of IL-10-producing B cells, the magnitude of Th1 inflammation decreased significantly over time, while patients with later recruitment of IL-10-producing B cells did not show this trend. The early IL-10-producing B cell recruiters also had significantly earlier recruitment of Tregs. Together, these data examined the lymphocyte infiltration in ALI and suggested an association between different lymphocyte subsets. Furthermore, the connection between earlier regulatory cell infiltration, decreasing Th1 inflammation, and better survival emphasized the importance of controlling inflammation during the initial stages of ALI.
The earlier presence of IL-10-producing B cells compared to Tregs suggests that these B cells may help establish a suppressive and anti-inflammatory environment before the arrival of Treg cells. In previous studies using autoimmune mouse models, the depletion of B cells prior to, but not after, the induction of experimental autoimmune encephalomyelitis increased the disease severity, suggesting that regulatory B cells functions by establishing a more anti-inflammatory environment [12] . In our cohort, the early recruiters had significantly better survival than the late recruiters and had significantly more reduction of Th1 inflammation over the sample collection period, suggesting a role of early IL-10-producing B cell recruitment in ALI resolution.
Whether IL-10-producing B cells could directly suppress Th1 inflammation through promoting Treg differentiation, and/or infiltration into the alveoli requires further study. IL-10 production by B cells and antibody-secreting plasmablasts was shown to inhibit dendritic cells in generating pathogenic T cells [19] , suppressed Th1 differentiation, promoted Tr1 cell and Treg cell differentiation, and suppressed IFN-gamma production from CD8 + T cells [16, 17] . Previous studies in parasitic helminth infection models also demonstrated a role of IL-10 from B cells in inducing pulmonary infiltration of CD4
+ Tregs, which controlled airway inflammations. These studies demonstrated that IL-10-produing B cells could act through multiple mechanisms in suppressing inflammation during ALI. The potential therapeutic uses of these mechanisms require further investigation.
We identified B cells with potential regulatory activities by using IL-10 production as a functional marker, instead of using other regulatory B cell markers, such as CD24 hi
CD38
hi and CD1d hi CD5 + , in autoimmune diseases and infections. Since some of these previous markers were shared with immature/transitional B cells and innate-like B-1 cells, we attempted to avoid mixing these cell types with our B cells of interest. The choice of IL-10, however, came with the caveat that IL-10 is also a B cell development and plasmablast differentiation cytokine. Indeed, our surface marker examination suggests that this IL-10-producing B cell population in the mini-BAL samples most closely resembled activated memory B cells or differentiating plasmablasts. Whether these B cells have proinflammatory roles, and whether they participate in host defense prior to ALI induction needs further studies.
